Virtual Medicinal Product (VMP)
-
Vedolizumab 300mg powder for solution for infusion vials
Name Details
Current Name
Vedolizumab 300mg powder for solution for infusion vials
|
Start Date
23-06-2014
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L04AG05
BNF |
Current BNF
01050300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01050300
|
Start Date
14-01-2015
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
24670211000001102 |
23-06-2014 |
|
VMP Ingredients
VMP ingredients table
Vedolizumab |
Based on Ingredient Substance |
|
300 mg |
|
Name
Vedolizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Parent Products
-
VTM
Vedolizumab
-
VMP
(Current) Vedolizumab 300mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information